This study by Mancini et al. (2021) examines how early treatment with selective serotonin reuptake inhibitors (SSRIs) affects cognition and brain development in individuals with 22q11.2 deletion syndrome (22q11DS). This syndrome is associated with a high risk for schizophrenia, making it an important focus for research into psychosis and its …
